Insys Therapeutics (INSY) Director Buys 10K Shares
- Oil steadies on doubts output cut will end global glut
- Western Digital (WDC) Raises Q2 Outlook
- Dollar edges up vs yen as traders eye ECB meeting for cues
- Mondelez Int'l (MDLZ) Seen as Kraft Heinz's (KHC) Next Logical Takeover Target - Credit Suisse
- Foxconn says in preliminary discussions to expand U.S. operations
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Insys Therapeutics (NASDAQ: INSY) Director, Steven Meyer, bought 10,000 shares on 11/04 at $10.75
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Peltz's Trian Adds Nearly 4M Shares of Wendy's (WEN)
- Corvex Management Cuts Signet Jewelers (SIG) Stake in Half
- UPDATE: Stone Energy (SGY): Thomas Satterfield Files 13D Showing 9.9% Stake, Challenges Restructuring Plan
Create E-mail Alert Related CategoriesInsider Trades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!